FDA recommends pause of Johnson & Johnson COVID-19 vaccine after blood clot cases
April 13 2021, 08:00
The Food and Drug Administration together with the Centers for Disease Control and Prevention (CDC) is recommending a pause in the rollout of the Johnson & Johnson COVID-19 vaccine after several instances of a severe blood clot in recipients.
The Food and Drug Administration together with the Centers for Disease Control and Prevention (CDC) is recommending a pause in the rollout of the Johnson & Johnson COVID-19 vaccine after several instances of a severe blood clot in recipients.
Source:
FOX News